423 related articles for article (PubMed ID: 11821900)
1. CCL27-CCR10 interactions regulate T cell-mediated skin inflammation.
Homey B; Alenius H; Müller A; Soto H; Bowman EP; Yuan W; McEvoy L; Lauerma AI; Assmann T; Bünemann E; Lehto M; Wolff H; Yen D; Marxhausen H; To W; Sedgwick J; Ruzicka T; Lehmann P; Zlotnik A
Nat Med; 2002 Feb; 8(2):157-65. PubMed ID: 11821900
[TBL] [Abstract][Full Text] [Related]
2. A possible role for CCL27/CTACK-CCR10 interaction in recruiting CD4 T cells to skin in human graft-versus-host disease.
Faaij CM; Lankester AC; Spierings E; Hoogeboom M; Bowman EP; Bierings M; Révész T; Egeler RM; van Tol MJ; Annels NE
Br J Haematol; 2006 Jun; 133(5):538-49. PubMed ID: 16681643
[TBL] [Abstract][Full Text] [Related]
3. Presence of circulating CCR10+ T cells and elevated serum CTACK/CCL27 in the early stage of mycosis fungoides.
Fujita Y; Abe R; Sasaki M; Honda A; Furuichi M; Asano Y; Norisugi O; Shimizu T; Shimizu H
Clin Cancer Res; 2006 May; 12(9):2670-5. PubMed ID: 16675558
[TBL] [Abstract][Full Text] [Related]
4. CCL27 is a critical factor for the development of atopic dermatitis in the keratin-14 IL-4 transgenic mouse model.
Chen L; Lin SX; Agha-Majzoub R; Overbergh L; Mathieu C; Chan LS
Int Immunol; 2006 Aug; 18(8):1233-42. PubMed ID: 16735375
[TBL] [Abstract][Full Text] [Related]
5. Increased CCL27-CCR10 expression in allergic contact dermatitis: implications for local skin memory.
Moed H; Boorsma DM; Tensen CP; Flier J; Jonker MJ; Stoof TJ; von Blomberg BM; Bruynzeel DP; Scheper RJ; Rustemeyer T; Gibbs S
J Pathol; 2004 Sep; 204(1):39-46. PubMed ID: 15307136
[TBL] [Abstract][Full Text] [Related]
6. Involvement of CCL27-CCR10 interactions in drug-induced cutaneous reactions.
Tapia B; Padial A; Sánchez-Sabaté E; Alvarez-Ferreira J; Morel E; Blanca M; Bellón T
J Allergy Clin Immunol; 2004 Aug; 114(2):335-40. PubMed ID: 15316512
[TBL] [Abstract][Full Text] [Related]
7. CTACK/CCL27 accelerates skin regeneration via accumulation of bone marrow-derived keratinocytes.
Inokuma D; Abe R; Fujita Y; Sasaki M; Shibaki A; Nakamura H; McMillan JR; Shimizu T; Shimizu H
Stem Cells; 2006 Dec; 24(12):2810-6. PubMed ID: 16931770
[TBL] [Abstract][Full Text] [Related]
8. New avenues for anti-inflammatory therapy.
Mackay CR
Nat Med; 2002 Feb; 8(2):117-8. PubMed ID: 11821893
[No Abstract] [Full Text] [Related]
9. CCR4 and CCR10 are expressed on epidermal keratinocytes and are involved in cutaneous immune reaction.
Fujimoto S; Uratsuji H; Saeki H; Kagami S; Tsunemi Y; Komine M; Tamaki K
Cytokine; 2008 Oct; 44(1):172-8. PubMed ID: 18782672
[TBL] [Abstract][Full Text] [Related]
10. Potential role of CCL27 and CCR10 expression in melanoma progression and immune escape.
Simonetti O; Goteri G; Lucarini G; Filosa A; Pieramici T; Rubini C; Biagini G; Offidani A
Eur J Cancer; 2006 May; 42(8):1181-7. PubMed ID: 16644201
[TBL] [Abstract][Full Text] [Related]
11. Tumor necrosis factor-alpha-induced CTACK/CCL27 (cutaneous T-cell-attracting chemokine) production in keratinocytes is controlled by nuclear factor kappaB.
Vestergaard C; Johansen C; Otkjaer K; Deleuran M; Iversen L
Cytokine; 2005 Jan; 29(2):49-55. PubMed ID: 15598438
[TBL] [Abstract][Full Text] [Related]
12. Circulating clonal CLA(+) and CD4(+) T cells in Sezary syndrome express the skin-homing chemokine receptors CCR4 and CCR10 as well as the lymph node-homing chemokine receptor CCR7.
Sokolowska-Wojdylo M; Wenzel J; Gaffal E; Lenz J; Speuser P; Erdmann S; Abuzahra F; Bowman E; Roszkiewicz J; Bieber T; Tüting T
Br J Dermatol; 2005 Feb; 152(2):258-64. PubMed ID: 15727636
[TBL] [Abstract][Full Text] [Related]
13. Cutting edge: the orphan chemokine receptor G protein-coupled receptor-2 (GPR-2, CCR10) binds the skin-associated chemokine CCL27 (CTACK/ALP/ILC).
Homey B; Wang W; Soto H; Buchanan ME; Wiesenborn A; Catron D; Müller A; McClanahan TK; Dieu-Nosjean MC; Orozco R; Ruzicka T; Lehmann P; Oldham E; Zlotnik A
J Immunol; 2000 Apr; 164(7):3465-70. PubMed ID: 10725697
[TBL] [Abstract][Full Text] [Related]
14. CCL27-transgenic mice show enhanced contact hypersensitivity to Th2, but not Th1 stimuli.
Kagami S; Saeki H; Tsunemi Y; Nakamura K; Kuwano Y; Komine M; Nakayama T; Yoshie O; Tamaki K
Eur J Immunol; 2008 Mar; 38(3):647-57. PubMed ID: 18266301
[TBL] [Abstract][Full Text] [Related]
15. TARC augments TNF-alpha-induced CTACK production in keratinocytes.
Vestergaard C; Johansen C; Christensen U; Just H; Hohwy T; Deleuran M
Exp Dermatol; 2004 Sep; 13(9):551-7. PubMed ID: 15335355
[TBL] [Abstract][Full Text] [Related]
16. IL-17 suppresses TNF-alpha-induced CCL27 production through induction of COX-2 in human keratinocytes.
Kanda N; Koike S; Watanabe S
J Allergy Clin Immunol; 2005 Nov; 116(5):1144-50. PubMed ID: 16275389
[TBL] [Abstract][Full Text] [Related]
17. CCR10 and CCL27 are overexpressed in cutaneous squamous cell carcinoma.
Kai H; Kadono T; Kakinuma T; Tomita M; Ohmatsu H; Asano Y; Tada Y; Sugaya M; Sato S
Pathol Res Pract; 2011 Jan; 207(1):43-8. PubMed ID: 21144674
[TBL] [Abstract][Full Text] [Related]
18. CCR4 versus CCR10 in human cutaneous TH lymphocyte trafficking.
Soler D; Humphreys TL; Spinola SM; Campbell JJ
Blood; 2003 Mar; 101(5):1677-82. PubMed ID: 12406880
[TBL] [Abstract][Full Text] [Related]
19. Prostaglandin E(2) suppresses CCL27 production through EP2 and EP3 receptors in human keratinocytes.
Kanda N; Mitsui H; Watanabe S
J Allergy Clin Immunol; 2004 Dec; 114(6):1403-9. PubMed ID: 15577845
[TBL] [Abstract][Full Text] [Related]
20. Expression of vascular endothelial growth factor, apoptosis inhibitors (survivin and p16) and CCL27 in alopecia areata before and after diphencyprone treatment: an immunohistochemical study.
Simonetti O; Lucarini G; Bernardini ML; Simoncini C; Biagini G; Offidani A
Br J Dermatol; 2004 May; 150(5):940-8. PubMed ID: 15149507
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]